AZD6244 (ARRY-142886) versus capecitabine (CAP) in patients (pts) with metastatic colorectal cancer (mCRC) who have failed prior chemotherapy
暂无分享,去创建一个
Tae-You Kim | I. Láng | J. Douillard | A. Adenis | P. Escudero | N. Sanders | K. Boér | M. Valladares | G. Pover